American Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.57M Sell
27,972
-772
-3% -$96.4K 0.48% 31
2025
Q4
$3.5M Sell
28,744
-6,960
-19% -$798K 0.45% 31
2025
Q3
$3.58M Sell
35,704
-10,357
-22% -$933K 0.46% 31
2025
Q2
$3.82M Sell
46,061
-1,366
-3% -$109K 0.53% 30
2025
Q1
$3.85M Sell
47,427
-826
-2% -$73.8K 0.56% 30
2024
Q4
$4.35M Sell
48,253
-4,352
-8% -$422K 0.61% 30
2024
Q3
$5.2M Sell
52,605
-3,193
-6% -$314K 0.71% 29
2024
Q2
$5.17M Sell
55,798
-8,089
-13% -$725K 0.74% 28
2024
Q1
$6.06M Sell
63,887
-5,298
-8% -$492K 0.85% 28
2023
Q4
$6.18M Sell
69,185
-6,930
-9% -$515K 0.91% 27
2023
Q3
$5.56M Sell
76,115
-30,618
-29% -$2.45M 0.88% 27
2023
Q2
$8.88M Sell
106,733
-145,262
-58% -$12.1M 1.39% 22
2023
Q1
$19.2M Sell
251,995
-11,208
-4% -$930K 3.13% 12
2022
Q4
$21.8M Sell
263,203
-7,483
-3% -$606K 3.7% 12
2022
Q3
$21.5M Sell
270,686
-9,431
-3% -$795K 3.71% 11
2022
Q2
$20.8M Sell
280,117
-8,366
-3% -$628K 5.52% 8
2022
Q1
$25.9M Buy
288,483
+46,255
+19% +$4.27M 3.6% 13
2021
Q4
$27.1M Buy
242,228
+5,298
+2% +$639K 3.45% 12
2021
Q3
$29.8M Buy
236,930
+25,386
+12% +$3.27M 3.98% 8
2021
Q2
$28.6M Buy
211,544
+9,790
+5% +$1.29M 3.94% 8
2021
Q1
$27.4M Buy
201,754
+23,407
+13% +$3.5M 4.07% 8
2020
Q4
$25.1M Buy
178,347
+2,682
+2% +$344K 3.58% 6
2020
Q3
$19.6M Sell
175,665
-8,162
-4% -$915K 3.18% 11
2020
Q2
$20.6M Sell
183,827
-7,465
-4% -$735K 3.3% 10
2020
Q1
$18.8M Sell
191,292
-7,041
-4% -$623K 3.37% 10
2019
Q4
$15.2M Buy
198,333
+41,044
+26% +$3.55M 2.66% 16
2019
Q3
$12M Buy
157,289
+1,688
+1% +$140K 2.27% 18
2019
Q2
$13.6M Buy
155,601
+1,279
+0.8% +$109K 2.66% 16
2019
Q1
$14M Sell
154,322
-25,184
-14% -$2.14M 2.85% 15
2018
Q4
$12.9M Buy
+179,506
New +$14.5M 2.82% 16

Other funds holding XBI